Our in vivo results showed that Nok significantly reversed the body weight, liver weight and liver index increases in MAFLD mice, ameliorated glucose and lipid metabolism disorders, and improved liver function and glucose tolerance damage compared to MAFLD mice. Here, STYK1 is linked to glucose measurement.